Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial - The Lancet

Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial  The Lancet

Strongyloides stercoralis infection is a neglected condition that places people who are immunocompromised at risk of hyperinfection and death. Ivermectin is the ...



Comments

Popular posts from this blog

SARS-CoV-2 virus may be shed for much longer periods by some infected patients, study shows - News-Medical.Net

This Nurse Built a Clinic in the Sierra Leone Village Where She Grew Up. That’s Just the Beginning. - Direct Relief